Načítá se...
Long-Term Survival in Gastroesophageal Junction Adenocarcinoma: Ramucirumab
We report a case of long-term survival with complete response of liver metastases within RAINBOW, a randomized, controlled trial of ramucirumab 8 mg/kg intravenously (days 1, 15) versus placebo, both plus paclitaxel 80 mg/m(2) intravenously (days 1, 8, 15), every 4 weeks in patients with previously...
Uloženo v:
| Vydáno v: | Case Rep Gastroenterol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
S. Karger AG
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6167727/ https://ncbi.nlm.nih.gov/pubmed/30283289 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000490906 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|